Viewing data from:

DEXTROAMPHETAMINE SULFATE

ANDA

DEXTROAMPHETAMINE SULFATE | A076353 | SPECGX LLC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: DEXEDRINE SPANSULE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$1.23

per ea

Lowest NADAC/Unit

$0.9617

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00406896201DEXTROAMPHETAMINE ER 15 MG CAP	$1.23	EA	Generic	—	2026-08-19
00406896101DEXTROAMPHETAMINE ER 10 MG CAP	$1.01	EA	Generic	—	2026-08-19
00406896001DEXTROAMPHETAMINE ER 5 MG CAP	$0.9617	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$84.63

Highest Price

$194.61

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00406-8960-01Dextroamphetamine Sulfate ER Capsules (5mg)	$84.63	FSS	SpecGx LLC	09/14/2027
00406-8961-01Dextroamphetamine Sulfate ER Capsules (10mg)	$132.66	FSS	SpecGx LLC	09/14/2027
00406-8962-01Dextroamphetamine Sulfate ER Capsules (15mg)	$194.61	FSS	SpecGx LLC	09/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs1 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

VERANOVA LPDEXTROAMPHETAMINE SULFATE

DMF 147832000

CAMBREX CHARLES CITY INCDEXTROAMPHETAMINE SULFATE USP

DMF 153072001

SPECGX LLCDEXTROAMPHETAMINE SULFATE USP

DMF 153852001

CURIA NEW YORK INCDEXTROAMPHETAMINE SULFATE USP

DMF 160212002

VERANOVA LPDEXTROAMPHETAMINE SULFATE USP

DMF 235832010

SIEGFRIED USA LLCDEXTROAMPHETAMINE SULFATE

DMF 296042016

CHATTEM CHEMICALS INCDEXTROAMPHETAMINE SULFATE USP

DMF 312442017

ISP FREETOWN FINE CHEMICALS INCInactiveDEXTROAMPHETAMINE SULFATE

DMF 156072001

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

CAPSULE, EXTENDED RELEASE;ORAL | Approved: May 6, 2003

No patent or exclusivity listings for this strength.

#002 — 10MG

0 patents0 exclusivities▾

CAPSULE, EXTENDED RELEASE;ORAL | Approved: May 6, 2003

#003 — 15MG

0 patents0 exclusivities▾

CAPSULE, EXTENDED RELEASE;ORAL | Approved: May 6, 2003